On March 24, 2020 Facebook disabled without warning the account of Gregory Krasovsky, the founder of The Ukrainian-Russian-American Observer.
Attorney Greg Krasovsky
As a result, the following Facebook pages registered by Greg Krasovsky and linked to his account have been "disappeared"from/by Facebook.
- The Ukrainian-Russian-American Observer page: https://www.facebook.com/URA.Observer/
- The Law Offices of Gregory Krasovsky (Washington, DC): https://www.facebook.com/krasovsky911/
- The Law Offices of Gregory Krasovsky (Moscow, Russia)
(Юридическая консультация Григория Красовского): https://www.facebook.com/krasovsky112/
- Greg Krasovsky's personal Facebook page: https://www.facebook.com/gkrasovsky
FYI, Greg Krasovsky is a dual US-Russian citizen and a practicing lawyer in both the United States and Russia.
He was born in Moscow, Russia in 1968 and spent the first 4 years of his life in Eastern Ukraine's Donetsk Coal Basin, namely Lugansk Region.
Since then Greg has spent have of his life in Russia (22 years) and the other half (23 years) in the United States. he also managed to live in Vienna, Austria for over a year before coming to the United States and settling in Philadelphia, PA.
So why did Facebook disable Greg's account without notice on the 24th?
Because Greg, having logged into his Facebook account from Moscow, Russia made an informative post on the COVID-19, the Wuhan Coronavirus (see below).
Now that you have read this post, do you think it was improper or in violation of Facebook rules & policies?
Regardless, after posting it on his personal Facebook page, Greg decided to share this post with his community groups at
1. Columbia University, where he received a BA in Political Science in 1991
- Columbia College Class of 1991 page
- Columbia College Class of 1990 page (Greg's original year)
- CU Alum Sheltering At Home
- KDR fraternity's page (Nu Alpha Alumni Corporation of Kappa Delta)
2. Central High School of Philadelphia, where he received his high school diploma (CHS is the only HS in the U.S. that awards a Bachelor of Arts degree!)
- The Official Central High School in Philadelphia Alumni Group
- Central High School in Philadelphia.
Apparently, such brazen activity was enough to trigger some Facebook protocol -- probably designed to fight those ominous Kremlin-controlled Russian Trolls that spread dissent and division among Americans -- which probably immediately declared Russian-American attorney Greg Krasovsky a violator Facebook policies and a threat to the Facebook ecosystem.
That's Facebook censorship for you!
After his account was disabled, Greg tried to follow recommended Facebook protocol for asking a review of his disabled account.
Unfortunately, the only thing that Facebook allowed Greg to do was to upload a photo of his U.S. passport with a subsequent promise to contact him by email shortly.
So now the only recourse that Greg has to restore his Facebook pages is to sue Facebook either in the U.S. or in Russia.
Why did Greg post his article on COVID-19, a very important and sensitive topic today?
Could Greg's previous life & work experience, including at the following places, have given him interest and insight into the COVID-19 pandemic?
Here's some of Greg Krasovsky's past work & volunteer experience:
- Work as a student intern/laboratory technician at University of Pennsylvania Medical School's Pharmacology Department (fields: Neuro-pharmacology & study of HIV virus);
- Volunteering at the American Red Cross' Disaster Services Division in New York City while attending Columbia University;
- Work as an Emergency Medical Technician at Columbia University in New York and in Pennsylvania (Montgomery County and City of Philadelphia);
- Work as a Fire Rescue and Vehicle Rescue Technician in Montgomery County, Pennsylvania;
- Work as a City of Philadelphia Police Officer;
- Work as a project manager overseeing a Biotechnology start-up in Russia that was involved in transgenics (human-animal DNA transfer & hybrids) and immunity boosting compounds;
- Volunteer work at an International Disaster Relief NGO, Shelterbox USA, including as its local representative in Washington, DC;
- Volunteer work as a founding member of an International Disaster Relief NGO, Disaster Aid USA; and
- Current work as an attorney who handles Medical Malpractice, Dangerous Drug Claims and Biochemistry Industry clients, as well as COVID-19 related legal cases.
Did Greg's work as an emergency responder (Police, Fire and EMS) and a disaster-relief volunteer create a life-long desire to help others by sharing in his Facebook community what he considered to be pertinent & important information?
Do we want people like Greg to share with us such information on Facebook regarding COVID-19?
Is this constitutionally protected free-speech?
Should Facebook have the power to unilaterally censor and banish its users, including those who have spent serious amounts of money on Facebook advertising for their businesses?
If you believe that such capricious Facebook banishment and censorship is improper and unwarranted, then please speak up!
Share this post among your friends and let Facebook know how you feel!
Also, please feel free to reach out to Greg Krasovsky by phone at +1-202-558-5287 or by email at <krasovsky911[at]gmail.com> and let him know you position and advice on this issue!
P.S. If you're interested, you can still find information on Greg Krasovsky's work and opinions on the internet outside of Facebook:
1. The Law Office of Gregory Krasovsky (Washington, DC):
YouTube channel (English): https://www.youtube.com/channel/UC6N9WNZiCUmj3FUxqbi6XrA/
2. The Law Office of Gregory Krasovsky (Moscow, Russia):
YouTube channel (Russian): https://www.youtube.com/channel/UCKdBlI6oxPo2HdGJPqYFiAA/
V Kontakte: http://vk.com/krasovsky112
Live Journal: http://krasovsky112.livejournal.com
3. The Ukrainian-Russian-American Observer (a blog on politics, economics, law, industry, science society and culture by a Ukrainian-Russian-American):
Greg Krasovsky's supposedly evil post on COVID-19
*Read at you own peril - you might learn something about the current state of the COVID-19 pandemic and potential treatment options!!!
Originally posted on March 24, 2020 at https://www.facebook.com/gkrasovsky/posts/10157444241553742
Bad news and good news re Covid-19
A. Good News:
1. "...our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction / disappearance in COVID-19 patients and its effect is reinforced by azithromycin."
2, High Dose IV Vitamin C treatments seem to help too!
3. Alcohol (>30%) kills coronavirus -- seems to dissolve its fatty shell.
4. The LA Times Video "The Science Behind the Coronavirus, the complete series" gives good overview of Covid-19.
5. China's successful battle with Covid-19, especially in Wuhan & its surrounding province, shows that we can beat this thing with strict epidemiological control measures (quarantine, isolation & social distancing).
6. No matter how bad Covid-19 is, it's still not as bad as the Spanish Flu of 1918 (which seems to have originated from a U.S. pig farm in Kansas).
B. Bad News:
1. Just look at today's numbers on Covid-19's spread.
2. The data from Wuhan shows how difficult it is to treat this thing.
3. 1/3 of Covid-19 carriers (and transmitters) don't show symptoms.
4. Unless we're ready and able to implement a simultaneous world-wide 4 to 6 week strict quarantine, we may not be able to stop the virus' spread and periodic reappearance domestically and from abroad.
So what do you think?
Information for Clinicians on Therapeutic Options for COVID-19 Patients
There are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19.
At present clinical management includes infection prevention and control measures and supportive care, including supplementary oxygen and mechanical ventilatory support when indicated. An array of drugs approved for other indications as well as several investigational drugs are being studied in several hundred clinical trials that are underway across the globe. The purpose of this document is to provide information on two of the approved drugs (chloroquine and hydroxychloroquine) and one of the investigational agents (remdesivir) currently in use in the United States.
Remdesivir is an investigational intravenous drug with broad antiviral activity that inhibits viral replication through premature termination of RNA transcription and has in-vitro activity against SARS-CoV-2 and in-vitro and in-vivo activity against related betacoronaviruses [1-3].
Finally, in areas without clinical trials, COVID-19 patients in the United States and other countries have been treated with remdesivir on an uncontrolled compassionate use basis. The manufacturer is currently transitioning the provision of emergency access to remdesivir from individual compassionate use requests to an expanded access program. The expanded access program for the United States is under rapid development. Further information is available at: https://rdvcu.gilead.com/external icon
Hydroxychloroquine and Chloroquine
Due to higher in-vitro activity against SARS-CoV-2 and its wider availability in the United States compared with chloroquine, hydroxychloroquine has been administered to hospitalized COVID-19 patients on an uncontrolled basis in multiple countries, including in the United States. One small study reported that hydroxychloroquine alone or in combination with azithromycin reduced detection of SARS-CoV-2 RNA in upper respiratory tract specimens compared with a non-randomized control group but did not assess clinical benefit . Hydroxychloroquine and azithromycin are associated with QT prolongation and caution is advised when considering these drugs in patients with chronic medical conditions (e.g. renal failure, hepatic disease) or who are receiving medications that might interact to cause arrythmias.
Hydroxychloroquine is currently under investigation in clinical trials for pre-exposure or post-exposure prophylaxis of SARS-CoV-2 infection, and treatment of patients with mild, moderate, and severe COVID-19. In the United States, several clinical trials of hydroxychloroquine for prophylaxis or treatment of SARS-CoV-2 infection are planned or will be enrolling soon. More information on trials can be found at: https://clinicaltrials.gov/external icon.
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Patients and methods
French Confirmed COVID-19 patients were included in a single arm protocol from early March to March 16th, to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting.
Depending on their clinical presentation, azithromycin was added to the treatment. Untreated patients from another center and cases refusing the protocol were included as negative controls. Presence and absence of virus at Day6-post inclusion was considered the end point.
Six patients were asymptomatic, 22 had upper respiratory tract infection symptoms and eight had lower respiratory tract infection symptoms.
Twenty cases were treated in this study and showed a significant reduction of the viral carriage at D6-post inclusion compared to controls, and much lower average carrying duration than reported of untreated patients in the literature. Azithromycin added to hydroxychloroquine was significantly more efficient for virus elimination.
Despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by azithromycin.
Hydroxychloroquine (HCQ), sold under the brand name Plaquenil among others, is a medication used for the prevention and treatment of certain types of malaria. Specifically it is used for chloroquine-sensitive malaria. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda. It is taken by mouth.
It is also being used as an off-label treatment for infection by Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). Experimental trials for this indication began in March 2020.
Azithromycin was discovered in 1980, and approved for medical use in 1988. It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.
In the United States, it is about US$4 for a course of treatment as of 2018. In 2016, it was the 49th most prescribed medication in the United States with more than 15 million prescriptions.
Use of high dose intravenous vitamin C (IVC) in the treatment of moderate to severe cases of Covid-19 patients.
A group of medical doctors, healthcare providers and scientists met online March 17, 2020, to discuss the use of high dose intravenous vitamin C (IVC) in the treatment of moderate to severe cases of Covid-19 patients.
Dr. Enqian Mao was in attendance, he is the chief of emergency medicine department at Ruijin Hospital, a major hospital in Shanghai, affiliated with the Joatong University College of Medicine. Dr. Mao is also a member of the Senior Expert Team at the Shanghai Public Health Center, where all Covid-19 patients have been treated.
Dr. Mao stated that his group treated about 50 cases of moderate to severe cases of Covid-19 infection with high dose IVC. Dosing of IVC ranged from 10,000 mg – 20,000 mg a day for 7-10 days, with 10,000 mg for moderate cases and 20,000 for more severe cases. The first bit of good news was that all patients who received IVC improved and there was no mortality. Secondly, as compared to the average of a 30-day hospital stay for all Covid-19 patients, those patients who received high dose IVC had a hospital stay about 3-5 days shorter than the overall patients.
Dr. Mao also discussed one particularly severe case where the patient was deteriorating rapidly. An extra of 50,000 mg IVC dosage was given over a period of 4 hours and it caused the patient’s pulmonary (oxygenation index) status to stabilize and improve as the critical care team watched in real time.
Why whisky could kill the coronavirus (but drinking it won’t work)
The virus that causes Covid-19 appears more vulnerable than Sars, which means a 40 per cent solution, typically found in alcoholic spirits, can be enough to destroy it
Researchers stress that downing shots is not recommended but strong liquor could be used as an emergency sanitiser
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)
Coronavirus Cases (worldwide):
COVID-19: U.S. at a Glance*
March 23, 2020
Total cases: 33,404
Total deaths: 400
Jurisdictions reporting cases: 54 (50 states, District of Columbia, Puerto Rico, Guam, and US Virgin Islands)
So you're not feeling well. But is it COVID-19?
Start with the symptoms, says Dr. Melanie Bernitz, Medical Director for Columbia Health.
For more tips and expert guidance from our faculty and researchers:
Children and Coronavirus Disease 2019 (COVID-19)
Tips to keep children healthy while school’s out
Steps to protect children from getting sick
You can encourage your child to help stop the spread of COVID-19 by teaching them to do the same things everyone should do to stay healthy.
- Clean hands often using soap and water or alcohol-based hand sanitizer
- Avoid people who are sick (coughing and sneezing)
- Clean and disinfect high-touch surfaces daily in household common areas (e.g. tables, hard-backed chairs, doorknobs, light switches, remotes, handles, desks, toilets, sinks)
- Launder items including washable plush toys as appropriate in accordance with the manufacturer’s instructions. If possible, launder items using the warmest appropriate water setting for the items and dry items completely. Dirty laundry from an ill person can be washed with other people’s items.
Coronavirus: Experts uncover how COVID-19 affects young people | Nine News Australia -
A third of coronavirus cases may be 'silent carriers', classified Chinese data suggests.
Nearly 30% of US coronavirus cases have been among people 20-44 years old, the CDC says — showing that young people are getting sick, too.
Almost half of coronavirus patients experience nausea, vomiting, or diarrhea before they get a fever. It could be one of the first signs of COVID-19 infection.
Coronavirus infects faster and lasts longer than Sars, raising new containment challenges, Chinese study suggests.
Researchers found that on average, infected people expel virus particles from their bodies for a relatively long period of 20 days, even before symptoms appear
Findings indicate longer quarantine periods may be needed for patients, according to researchers from the China-Japan Friendship Hospital.
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.
The Science Behind the Coronavirus, the complete series
Mar 18, 2020
Los Angeles Times
Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times, offers an overview of our special series, The Science Behind the Coronavirus.
In this introduction, Soon-Shiong (MD, MBBCh, MSc, FRCS (C), FACS) proposes that understanding how the virus infects our bodies and strategies toward treatment can help us allay our anxiety about it.
Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases.
He is also the chairman and CEO of NantWorks and the owner of or investor in a number of companies, including ImmunityBio and NantKwest which are currently researching immunotherapies for COVID-19.
1918 Spanish Flu historical documentary | Swine Flu Pandemic | Deadly plague of 1918
Oct 2, 2018
Historical documentary about 1918 Swine Flu or Spanish Flu and the role of World War I in spreading the disease among troops making it into a worldwide plague of devastating proportions.
The video covers where it began, how and where it spread, the symptoms, how it affected America and whether it could happen again.
Spanish Flu: a warning from history
Nov 30, 2018
100 years ago, celebrations marking the end of the First World War were cut short by the onslaught of a devastating disease - the 1918-19 influenza pandemic.
Its early origins and initial geographical starting point still remain a mystery but in the Summer of 1918, there was a second wave of a far more virulent form of the influenza virus than anyone could have anticipated.
Soon dubbed ‘Spanish Flu’ after its effects were reported in the country’s newspapers, the virus rapidly spread across much of the globe to become one of the worst natural disasters in human history.
To mark the centenary and to highlight vital scientific research, the University of Cambridge has made a new film exploring what we have learnt about Spanish Flu, the urgent threat posed by influenza today, and how scientists are preparing for future pandemics.